Bank Of New York Mellon Corp Pds Biotechnology Corp Transaction History

Bank Of New York Mellon Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.28 - $13.2 $207,889 - $836,629	63,381 New	63,381 $836,000
Q2 2022 Aug 15, 2022	SELL	$3.05 - $6.68 $1,851 - $4,054	-607 Reduced 1.57%	38,150 $139,000
Q2 2021 Aug 11, 2021	BUY	$4.35 - $12.86 $21,123 - $62,448	4,856 Added 14.32%	38,757 $486,000
Q1 2021 May 13, 2021	SELL	$2.28 - $6.81 $5,615 - $16,773	-2,463 Reduced 6.77%	33,901 $154,000
Q2 2020 Aug 12, 2020	SELL	$0.65 - $2.6 $0 - $2	-1 Reduced -0.0%	36,364 $73,000
Q1 2020 May 06, 2020	BUY	$0.67 - $3.04 $24,364 - $110,549	36,365 New	36,365 $26,000

4.05M

253K

70.4K

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $42.7M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.